Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

The minerals, metals & materials series

Quantum Computers and Hybrid Machine Learning Models for the Discovery of Lightweight Structural Alloys

S. V. MORE S. K. PANCHAL, Megh Raval, Raj Pandya, Vishvesh Badheka

Published Jan 1, 2026• 0 citations
Publisher
DOI
10.1007/978-3-032-13828-6_53

Related papers

Quantum Machine Learning for Materials Science

Zongrui Pei

The Materials Research Society series•Jan 1, 2026•1 citation

Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug Discovery

Matthew A. Dorsey, Kelvin Dsouza, Dhruv Ranganath +4 more

Computational approaches are widely applied in drug discovery to explore properties related to bioactivity, physiochemistry, and toxicology. Over at least the last 20 years, the exploitation of machine learning on molecular data sets has been used to understand the structure–activity relationships that exist between biomolecules and druggable targets. More recently, these methods have also seen application for phenotypic screening data for neglected diseases such as tuberculosis and malaria. Herein, we apply machine learning to build quantum Quantitative Structure Activity Relationship models from antimalarial data sets. There is a continual need for new antimalarials to address drug resistance, and the readily available in vitro data sets could be utilized with newer machine learning approaches as these develop. Furthermore, quantum machine learning is a relatively new method that uses a quantum computer to perform the calculations. First, we present a classical-quantum hybrid computational approach by building a Latent Bernoulli Autoencoder machine learning model for compressing bit-vector descriptors to a size that can be adapted to quantum computers for classification tasks with limited loss of embedded information. Second, we apply our method for feature map compression to quantum classification algorithms, including a completely novel machine learning algorithm with no analogy in classical computers: the Quantum Fourier Transform Classifier. We apply both these approaches to build quantum machine learning models for small-molecule antimalarials with quantum simulation software and then benchmark these quantum models against classical machine learning approaches. While there are many challenges currently facing the development of reliable quantum computers, our results demonstrate that there is potential for the use of this technology in the field of drug discovery.

Journal of Chemical Information and Modeling•Jul 16, 2024•8 citations

Designing complex concentrated alloys with quantum machine learning and language modeling

Zongrui Pei, Yilun Gong, Xianglin Liu +1 more

Matter•Jun 21, 2024•13 citations

Empirical Study of Quantum Machine Learning Algorithms for Accelerating Functional Materials Discovery

Doris Ngozi Nwachuku, Ericdavid E. Ugochukwu

Quantum machine learning (QML) represents a convergence of quantum computing and statistical learning theory with transformative potential for high-throughput computational materials discovery. This empirical study systematically benchmarks six QML architectures — quantum kernel support vector machines, variational quantum eigensolvers augmented by graph neural networks, quantum approximate optimization algorithm hybrids, quantum random forests, quantum Boltzmann machines, and parameterized quantum circuit-based neural networks — against their classical analogues across five material classes comprising perovskite oxides, battery cathode materials, two-dimensional semiconductor alloys, metal-organic frameworks, and high-entropy alloys. Using 14,720 DFT-computed property records drawn from the Materials Project and AFLOW databases as the common evaluation corpus, the QML methods achieved mean absolute error reductions of 38–61% and training time compressions of 29–61% relative to equivalent classical estimators at equivalent dataset sizes. The quantum random forest architecture exhibited the strongest overall performance (MAE = 0.026 eV; R² = 0.978), while hardware-native implementations on IBM Quantum Eagle and IonQ Forte achieved practical speed-ups of 28x–41x over CPU-based baselines. Barren plateau pathology and noise-induced gradient suppression remained the principal barriers to scaling beyond 50 qubits on current NISQ hardware. The empirical results of this study established principal conclusions that advance the theoretical and practical understanding of QML in materials discovery contexts. These findings provide grounding for deploying QML in production materials informatics pipelines.

Nigerian Journal of Physics•Jun 19, 2026•0 citations

Quantum machine-learning phase prediction of high-entropy alloys

Payden Brown, Houlong L. Zhuang

Materials Today•Mar 1, 2023•44 citations

A Hybrid Quantum-Classical Machine Learning Framework for Accelerated Drug Discovery

Sriramadasu Sri Sainadh, Saigeetha S.B., Jeeru Bharath Reddy +4 more

The pharmaceutical industry faces mounting challenges in drug discovery, where exploring a chemical space exceeding 10 60 possible compounds remains computationally prohibitive. Traditional in-silico screening approaches struggle to capture the quantum mechanical interactions that determine molecular behavior. To overcome these limitations, this study introduces a hybrid quantum–classical machine learning framework that uniquely integrates molecular graph theory with quantum-enhanced learning for accelerated drug discovery. Using the QM9 benchmark dataset containing 133,885 molecules of low-to-medium structural complexity, we extract Laplacian eigenvalue spectra as topological descriptors that preserve both connectivity and electronic information. These features are jointly processed by Random Forest (RF), Support Vector Machine (SVM), and a Variational Quantum Classifier (VQC) in a weighted ensemble architecture designed for balanced generalization. The Quantum Graph Neural Network (QGNN) component achieves 97.5% accuracy, while the hybrid ensemble attains 100.0% accuracy, confirming strong predictive reliability. Although quantum training requires roughly 3.2× longer computation, it captures high-dimensional correlations that classical methods overlook. Overall, the proposed framework bridges the gap between theoretical quantum computing and practical pharmaceutical modeling, providing a scalable, physics-inspired pathway toward intelligent molecular screening and next-generation drug discovery systems.

Procedia Computer Science•Jan 1, 2026•0 citations
Computational approaches are widely applied in drug discovery to explore properties related to bioactivity, physiochemistry, and toxicology. Over at least the last 20 years, the exploitation of machine learning on molecular data sets has been used to understand the structure–activity relationships that exist between biomolecules and druggable targets. More recently, these methods have also seen application for phenotypic screening data for neglected diseases such as tuberculosis and malaria. Herein, we apply machine learning to build quantum Quantitative Structure Activity Relationship models from antimalarial data sets. There is a continual need for new antimalarials to address drug resistance, and the readily available in vitro data sets could be utilized with newer machine learning approaches as these develop. Furthermore, quantum machine learning is a relatively new method that uses a quantum computer to perform the calculations. First, we present a classical-quantum hybrid computational approach by building a Latent Bernoulli Autoencoder machine learning model for compressing bit-vector descriptors to a size that can be adapted to quantum computers for classification tasks with limited loss of embedded information. Second, we apply our method for feature map compression to quantum classification algorithms, including a completely novel machine learning algorithm with no analogy in classical computers: the Quantum Fourier Transform Classifier. We apply both these approaches to build quantum machine learning models for small-molecule antimalarials with quantum simulation software and then benchmark these quantum models against classical machine learning approaches. While there are many challenges currently facing the development of reliable quantum computers, our results demonstrate that there is potential for the use of this technology in the field of drug discovery.
Quantum machine learning (QML) represents a convergence of quantum computing and statistical learning theory with transformative potential for high-throughput computational materials discovery. This empirical study systematically benchmarks six QML architectures — quantum kernel support vector machines, variational quantum eigensolvers augmented by graph neural networks, quantum approximate optimization algorithm hybrids, quantum random forests, quantum Boltzmann machines, and parameterized quantum circuit-based neural networks — against their classical analogues across five material classes comprising perovskite oxides, battery cathode materials, two-dimensional semiconductor alloys, metal-organic frameworks, and high-entropy alloys. Using 14,720 DFT-computed property records drawn from the Materials Project and AFLOW databases as the common evaluation corpus, the QML methods achieved mean absolute error reductions of 38–61% and training time compressions of 29–61% relative to equivalent classical estimators at equivalent dataset sizes. The quantum random forest architecture exhibited the strongest overall performance (MAE = 0.026 eV; R² = 0.978), while hardware-native implementations on IBM Quantum Eagle and IonQ Forte achieved practical speed-ups of 28x–41x over CPU-based baselines. Barren plateau pathology and noise-induced gradient suppression remained the principal barriers to scaling beyond 50 qubits on current NISQ hardware. The empirical results of this study established principal conclusions that advance the theoretical and practical understanding of QML in materials discovery contexts. These findings provide grounding for deploying QML in production materials informatics pipelines.
The pharmaceutical industry faces mounting challenges in drug discovery, where exploring a chemical space exceeding 10 60 possible compounds remains computationally prohibitive. Traditional in-silico screening approaches struggle to capture the quantum mechanical interactions that determine molecular behavior. To overcome these limitations, this study introduces a hybrid quantum–classical machine learning framework that uniquely integrates molecular graph theory with quantum-enhanced learning for accelerated drug discovery. Using the QM9 benchmark dataset containing 133,885 molecules of low-to-medium structural complexity, we extract Laplacian eigenvalue spectra as topological descriptors that preserve both connectivity and electronic information. These features are jointly processed by Random Forest (RF), Support Vector Machine (SVM), and a Variational Quantum Classifier (VQC) in a weighted ensemble architecture designed for balanced generalization. The Quantum Graph Neural Network (QGNN) component achieves 97.5% accuracy, while the hybrid ensemble attains 100.0% accuracy, confirming strong predictive reliability. Although quantum training requires roughly 3.2× longer computation, it captures high-dimensional correlations that classical methods overlook. Overall, the proposed framework bridges the gap between theoretical quantum computing and practical pharmaceutical modeling, providing a scalable, physics-inspired pathway toward intelligent molecular screening and next-generation drug discovery systems.